Key Takeaways
- • UNC Health relaunched its venture capital fund with a $125 million capital infusion, a 12.5x increase from the original $10 million seed funding deployed in 2012 under the predecessor Rex Health Ventures.
- • The new UNC Health Ventures fund succeeds Rex Health Ventures, which supported nearly 30 early-stage healthcare companies over its 14-year operational period, demonstrating a track record of identifying promising healthcare technology investments.
- • Returns from Rex Health Ventures have exceeded total capital deployed, with more than half of the original capital still actively invested in portfolio companies, according to UNC Health's spokesman.
- • The fund sources capital from UNC Health's broader nonprofit investment portfolio, with income reinvested to support patient care, operations, and research across the health system.
- • UNC Health's CEO Cristy Page framed the fund as a strategic mechanism to engage with emerging healthcare innovations earlier while enabling clinicians to evaluate new care approaches that address real-world health system challenges.
Summary
UNC Health has relaunched its venture capital operation with $125 million in fresh capital dedicated to investing in emerging healthcare companies. The new entity, UNC Health Ventures, succeeds Rex Health Ventures, a fund established in 2012 with $10 million in initial seed capital. This represents a significant capital expansion, reflecting the health system's increased confidence in venture investing as a mechanism for accessing innovation.
Over its 14-year history, Rex Health Ventures supported nearly 30 early-stage companies developing equipment and therapies targeted at addressing healthcare challenges within UNC Health's patient population and operational ecosystem. According to UNC Health spokesman Alan Wolf, the predecessor fund has generated returns exceeding its total invested capital, with more than half of the original capital base remaining actively deployed in existing portfolio companies—indicating a material pipeline of potential future value realization.
The capital for the relaunched fund originates from UNC Health's broader investment portfolio. Generated returns are reinvested into the nonprofit health system to support patient care, operations, and research initiatives. UNC Health CEO and Dean of the UNC School of Medicine Cristy Page stated that the fund provides the organization with earlier engagement in promising healthcare advancements, enabling clinicians to evaluate emerging care methodologies while shaping solutions that address operational and clinical challenges across the health system.
The strategy reflects a broader trend among large health systems leveraging venture capital as both a financial and strategic tool—enabling direct exposure to innovation cycles while potentially improving patient outcomes and operational efficiency through internal portfolio company relationships.
Over its 14-year history, Rex Health Ventures supported nearly 30 early-stage companies developing equipment and therapies targeted at addressing healthcare challenges within UNC Health's patient population and operational ecosystem. According to UNC Health spokesman Alan Wolf, the predecessor fund has generated returns exceeding its total invested capital, with more than half of the original capital base remaining actively deployed in existing portfolio companies—indicating a material pipeline of potential future value realization.
The capital for the relaunched fund originates from UNC Health's broader investment portfolio. Generated returns are reinvested into the nonprofit health system to support patient care, operations, and research initiatives. UNC Health CEO and Dean of the UNC School of Medicine Cristy Page stated that the fund provides the organization with earlier engagement in promising healthcare advancements, enabling clinicians to evaluate emerging care methodologies while shaping solutions that address operational and clinical challenges across the health system.
The strategy reflects a broader trend among large health systems leveraging venture capital as both a financial and strategic tool—enabling direct exposure to innovation cycles while potentially improving patient outcomes and operational efficiency through internal portfolio company relationships.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.